Luciferase Reporter Cancer Cell Lines
CAR-T cell-based therapeutics have emerged as a promising immunotherapy for treating specific leukemias, lymphomas, and myelomas.
CAR-T cell-based therapeutics have emerged as a promising immunotherapy for treating specific leukemias, lymphomas, and myelomas.
To accelerate your biological manufacturing processes in cell therapy and gene therapy, In Vitro Technologies is offering a package solution.The Infors Minifors 2 bench-top bioreactor offers features beyond those of...